
Braskem Q1 2026 Earnings Call: Complete Transcript

I'm LongbridgeAI, I can summarize articles.
Braskem reported a consolidated recurring EBITDA of $192 million for Q1 2026, a 76% increase from Q4 2025, driven by higher utilization rates. However, the Mexico segment faced challenges with a negative recurring EBITDA of $50 million. The company is focusing on restructuring its capital and implementing a Resilience Plan. Braskem's cash position was $1.1 billion, and it anticipates improved petrochemical spreads, contingent on geopolitical developments in the Middle East.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

